Synthesis of new modified truncated peptides and inhibition of glycogen phosphorylase

Stephanie S. Schweiker, Wendy A. Loughlin, Christopher L. Brown, Gregory K. Pierens

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Abstract

The first solution state structural analysis (NMR) of the C-terminal sequence of human GL that binds to glycogen phosphorylase a (GPa), PEWPSYLGYEKLGPYY-NH2 (1), showed it to be in a random coil conformation. This was supported by molecular dynamics simulation (modelled in solution) using NAMD 2.6. The conformational ambiguity of the peptidemakes the structural arrangement of the peptide (and internal residues) strongly dependent on the environment. Thirteen tetra-peptide fragments of the C-terminal sequence, YEKLG-NH2, and the corresponding tri- and di-peptide sequences were used in a fragment screen against GPa. Compound 2 (H-GPYY-NH2) did not give an IC50 value, whereas PEWPSYLGYEKLGPYY-NH2 (1) displayed an IC50 of 34 μM against GPa. Truncated peptides derived from 1, (EKL-NH2, EKLG-NH2, and AcEKNH2) inhibited GPa (21%, 32%, 63%, respectively at 22mM). These studies suggest key residueswithin the peptide chain have additional molecular interactionswith GPa. The interaction of intra-sequence residues in combination with the terminal residues of PEWPSYLGYEKLGPYY with GPa may form the basis for the design of new inhibitors of GPa.

Original languageEnglish
Pages (from-to)442-450
Number of pages9
JournalJournal of Peptide Science
Volume15
Issue number6
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Phosphorylase a
Glycogen Phosphorylase
Peptides
Inhibitory Concentration 50
Peptide Fragments
Molecular Dynamics Simulation
Structural analysis
Conformations
Molecular dynamics
Nuclear magnetic resonance
Computer simulation

Cite this

Schweiker, Stephanie S. ; Loughlin, Wendy A. ; Brown, Christopher L. ; Pierens, Gregory K. / Synthesis of new modified truncated peptides and inhibition of glycogen phosphorylase. In: Journal of Peptide Science. 2009 ; Vol. 15, No. 6. pp. 442-450.
@article{f96942310a2f4ff7a415195ceb41fd83,
title = "Synthesis of new modified truncated peptides and inhibition of glycogen phosphorylase",
abstract = "The first solution state structural analysis (NMR) of the C-terminal sequence of human GL that binds to glycogen phosphorylase a (GPa), PEWPSYLGYEKLGPYY-NH2 (1), showed it to be in a random coil conformation. This was supported by molecular dynamics simulation (modelled in solution) using NAMD 2.6. The conformational ambiguity of the peptidemakes the structural arrangement of the peptide (and internal residues) strongly dependent on the environment. Thirteen tetra-peptide fragments of the C-terminal sequence, YEKLG-NH2, and the corresponding tri- and di-peptide sequences were used in a fragment screen against GPa. Compound 2 (H-GPYY-NH2) did not give an IC50 value, whereas PEWPSYLGYEKLGPYY-NH2 (1) displayed an IC50 of 34 μM against GPa. Truncated peptides derived from 1, (EKL-NH2, EKLG-NH2, and AcEKNH2) inhibited GPa (21{\%}, 32{\%}, 63{\%}, respectively at 22mM). These studies suggest key residueswithin the peptide chain have additional molecular interactionswith GPa. The interaction of intra-sequence residues in combination with the terminal residues of PEWPSYLGYEKLGPYY with GPa may form the basis for the design of new inhibitors of GPa.",
author = "Schweiker, {Stephanie S.} and Loughlin, {Wendy A.} and Brown, {Christopher L.} and Pierens, {Gregory K.}",
year = "2009",
doi = "10.1002/psc.1140",
language = "English",
volume = "15",
pages = "442--450",
journal = "Journal of Peptide Science",
issn = "1075-2617",
publisher = "John Wiley & Sons",
number = "6",

}

Synthesis of new modified truncated peptides and inhibition of glycogen phosphorylase. / Schweiker, Stephanie S.; Loughlin, Wendy A.; Brown, Christopher L.; Pierens, Gregory K.

In: Journal of Peptide Science, Vol. 15, No. 6, 2009, p. 442-450.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Synthesis of new modified truncated peptides and inhibition of glycogen phosphorylase

AU - Schweiker, Stephanie S.

AU - Loughlin, Wendy A.

AU - Brown, Christopher L.

AU - Pierens, Gregory K.

PY - 2009

Y1 - 2009

N2 - The first solution state structural analysis (NMR) of the C-terminal sequence of human GL that binds to glycogen phosphorylase a (GPa), PEWPSYLGYEKLGPYY-NH2 (1), showed it to be in a random coil conformation. This was supported by molecular dynamics simulation (modelled in solution) using NAMD 2.6. The conformational ambiguity of the peptidemakes the structural arrangement of the peptide (and internal residues) strongly dependent on the environment. Thirteen tetra-peptide fragments of the C-terminal sequence, YEKLG-NH2, and the corresponding tri- and di-peptide sequences were used in a fragment screen against GPa. Compound 2 (H-GPYY-NH2) did not give an IC50 value, whereas PEWPSYLGYEKLGPYY-NH2 (1) displayed an IC50 of 34 μM against GPa. Truncated peptides derived from 1, (EKL-NH2, EKLG-NH2, and AcEKNH2) inhibited GPa (21%, 32%, 63%, respectively at 22mM). These studies suggest key residueswithin the peptide chain have additional molecular interactionswith GPa. The interaction of intra-sequence residues in combination with the terminal residues of PEWPSYLGYEKLGPYY with GPa may form the basis for the design of new inhibitors of GPa.

AB - The first solution state structural analysis (NMR) of the C-terminal sequence of human GL that binds to glycogen phosphorylase a (GPa), PEWPSYLGYEKLGPYY-NH2 (1), showed it to be in a random coil conformation. This was supported by molecular dynamics simulation (modelled in solution) using NAMD 2.6. The conformational ambiguity of the peptidemakes the structural arrangement of the peptide (and internal residues) strongly dependent on the environment. Thirteen tetra-peptide fragments of the C-terminal sequence, YEKLG-NH2, and the corresponding tri- and di-peptide sequences were used in a fragment screen against GPa. Compound 2 (H-GPYY-NH2) did not give an IC50 value, whereas PEWPSYLGYEKLGPYY-NH2 (1) displayed an IC50 of 34 μM against GPa. Truncated peptides derived from 1, (EKL-NH2, EKLG-NH2, and AcEKNH2) inhibited GPa (21%, 32%, 63%, respectively at 22mM). These studies suggest key residueswithin the peptide chain have additional molecular interactionswith GPa. The interaction of intra-sequence residues in combination with the terminal residues of PEWPSYLGYEKLGPYY with GPa may form the basis for the design of new inhibitors of GPa.

UR - http://www.scopus.com/inward/record.url?scp=67649786881&partnerID=8YFLogxK

U2 - 10.1002/psc.1140

DO - 10.1002/psc.1140

M3 - Article

VL - 15

SP - 442

EP - 450

JO - Journal of Peptide Science

JF - Journal of Peptide Science

SN - 1075-2617

IS - 6

ER -